---
title: "Thalys corrects the equity structure of the capital increase and investment announcement of its subsidiary"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/257867424.md"
description: "Thalys Medical Technology Group Co., Ltd. issued a correction announcement, rectifying errors in the shareholder names and shareholding ratios in the announcement regarding the capital increase and investment in its subsidiary disclosed on September 18. After the correction, the shareholding ratio of \"Thalys Medical\" is adjusted from 49.00% to 41.00%, and the shareholding ratio of \"Weixin Biotechnology\" is adjusted from 41.00% to 49.00%. The company apologizes for the inconvenience caused by the correction and will strengthen the review of information disclosure"
datetime: "2025-09-18T08:47:24.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/257867424.md)
  - [en](https://longbridge.com/en/news/257867424.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/257867424.md)
---

# Thalys corrects the equity structure of the capital increase and investment announcement of its subsidiary

Thalys Medical Technology Group Co., Ltd. issued a correction announcement. The company disclosed on September 18th the "Announcement on the External Investment of Capital Increase in the Joint Venture Subsidiary and Joint Investment with the Actual Controller, as well as Related Transactions," which contained some errors and is now being corrected. The main adjustment is in the shareholder names and corresponding shareholding ratios in the equity structure of the target company after the acquisition is completed. The shareholding ratio of "Thalys Medical" changed from 49.00% to 41.00%, while "Wei Xin Biological" changed from 41.00% to 49.00%. At the same time, the relevant information in the "2025 Fifth Extraordinary Shareholders' Meeting Materials" is also being corrected. Other contents of the original announcement remain unchanged. The company apologizes for the inconvenience caused by this correction and will strengthen the review of information disclosure

### Related Stocks

- [603716.CN](https://longbridge.com/en/quote/603716.CN.md)

## Related News & Research

- [Trump faces record-low approval on inflation as retirees struggle](https://longbridge.com/en/news/286834439.md)
- [05:20 ETThrough the America's Most Artistic Kid Competition, Colossal Raises $1.6 Million While Celebrating the Next Gen of Creative Visionaries](https://longbridge.com/en/news/287037755.md)
- [09:06 ETHarmony Comes to the Massachusetts State House as The Platters® Prepare Their Musical Love Letter to the World](https://longbridge.com/en/news/286918739.md)
- [14:47 ET6th Annual Midwest Design Awards Entry Period Now Open](https://longbridge.com/en/news/286808240.md)
- [13:41 ETUT Haslam Marks Decade in Major International Ranking's Top Five U.S. Public Schools](https://longbridge.com/en/news/286804132.md)